Quantcast

Latest California Institute for Regenerative Medicine Stories

2014-07-17 08:30:21

SAN DIEGO, July 17, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately held regenerative medicine company developing a cell replacement therapy for the treatment of diabetes, today announced that it has filed an Investigational New Drug application (IND) with the United States Food and Drug Administration (FDA) seeking to initiate a Phase 1/2 clinical trial in patients with type 1 diabetes. The trial would evaluate the safety and efficacy of ViaCyte's VC-01(TM) product candidate, a stem...

2014-06-03 12:37:18

LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Translational Regenerative Medicine: Market Prospects 2014-2024http://www.reportbuyer.com/pharma_healthcare/research_r_d/translational_regenerative_medicine_market_prospects_2012_2022.html Report DetailsOur new study shows you the commercial potential of regenerative treatmentsWhat does the future hold for regenerative medicine? Visiongain's brand new report shows you potential revenues to...

2014-05-30 08:24:46

First Clinical Application of Genome Editing Technology in Hematopoietic Stem/Progenitor Cells RICHMOND, Calif., May 30, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that the California Institute for Regenerative Medicine (CIRM) has granted a $5.6 million Strategic Partnership Award to fund clinical studies at City of Hope to develop a potentially curative ZFP Therapeutic for HIV/AIDS based on the application of Sangamo's zinc finger nuclease (ZFN)...

2014-02-12 12:31:06

LONDON, Feb. 12, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Translational Regenerative Medicine: Market Prospects 2014-2024Report DetailsOur new study shows you the commercial potential of regenerative treatmentsWhat does the future hold for regenerative medicine? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there.Our study lets you assess regenerative medicine: cell-based...

2014-02-03 12:27:00

LONDON, Feb. 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Stem Cell Markets A stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate physiological or experimental conditions. Traditionally, stem cells have been classified as either embryonic, adult (tissue-specific or cord blood) stem cells. Recent understanding of stem cell biology...

2014-01-13 16:26:23

SAN DIEGO, Jan. 13, 2014 /PRNewswire/ -- Biocom, the association for the Southern California life sciences community, announced that its president and CEO, Joe Panetta, has been appointed to the California Institute for Regenerative Medicine's (CIRM) Independent Citizens' Oversight Committee (ICOC) by Governor Jerry Brown. (Logo: http://photos.prnewswire.com/prnh/20130228/LA69104LOGO) "This is an opportunity to work alongside patient advocates, researchers and leaders in the...

2013-11-05 23:04:29

Reportbuyer.com just published a new market research report: Stem Cell Markets. London (PRWEB) November 05, 2013 A stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate physiological or experimental conditions. Traditionally, stem cells have been classified as either embryonic, adult (tissue-specific or cord blood) stem cells. Recent understanding of stem cell biology may provide...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related